Sunshine Briefing Features Calls for Expansion of Reporting Requirements and An End To Drug Reps and Samples Read more
AdvaMed Releases Innovation Agenda: Proposes Device Tax Repeal; Automatic Coverage of FDA-Approved Clinical Trials Read more
CMS Issues Final Rule on Managing Conflicts of Interests in Medicare Prescription Drug Decisions Read more
FDA Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs Read more
Physician Payments Sunshine Act: Attend Registration and Data Submission Q&A Tuesday, February 10 Read more
FDA seeks $4.9 billion for FY 2016; Commissioner Hamburg Reflects on FDA’s Accomplishments Over the Past Year Read more